Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of the Relationship Between Serum Adiponectin and Clinical Prognosis in Patients Undergoing Cardiac Surgery

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2011 by Xijing Hospital.
Recruitment status was:  Not yet recruiting
Sponsor:
Information provided by:
Xijing Hospital
ClinicalTrials.gov Identifier:
NCT01393535
First received: July 11, 2011
Last updated: NA
Last verified: July 2011
History: No changes posted
  Purpose
The purpose of this study is to investigate the relationship between serum adiponectin and clinical prognosis in patients undergoing cardiac surgery.

Condition
Cardiac Surgery

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Study of the Relationship Between Serum Adiponectin and Clinical Prognosis in Patients Undergoing Cardiac Surgery

Resource links provided by NLM:


Further study details as provided by Xijing Hospital:

Estimated Enrollment: 800
Study Start Date: July 2011
Estimated Study Completion Date: August 2012
Estimated Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)
Detailed Description:
Adiponectin, an adipose tissue derived protein, is an abundant protein hormone regulatory of numerous metabolic processes. Since its discovery, adiponectin has garnered considerable attention for its role in cardiovascular pathology. It has been shown to be a predictor of cardiovascular events in both the general population and patients undergoing cardiac surgery. In this study,we are planning to investigate the relationship between serum adiponectin and clinical prognosis in patients undergoing cardiac surgery.
  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients underwent cardiac surgery in cardiovascular surgery department of xijing hospital.
Criteria

Inclusion Criteria:

  • Patients who had underwent cardiac surgery from July 2011 to August 2012 in xijing hospital.

Exclusion Criteria:

  • Nothing particular.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01393535

Locations
China, Shannxi
Xijing Hospital
Xi'an, Shannxi, China, 710032
Sponsors and Collaborators
Xijing Hospital
Investigators
Study Chair: Dinghua Yi, MD Xijing Hospital
  More Information

Responsible Party: Chunhu Gu, Xijing Hospital
ClinicalTrials.gov Identifier: NCT01393535     History of Changes
Other Study ID Numbers: Guch-013 
Study First Received: July 11, 2011
Last Updated: July 11, 2011
Health Authority: China: Food and Drug Administration

Keywords provided by Xijing Hospital:
Adiponectin
Prognosis
Cardiac Surgery

ClinicalTrials.gov processed this record on December 07, 2016